BRAZIL: Requirements for registration Anvisa effective March 1
The brazilian resolution RDC No.751/2022 Dispõe sobre a classificação de risco, os regimes de notificação e de registro, e os requisitos [...]
The brazilian resolution RDC No.751/2022 Dispõe sobre a classificação de risco, os regimes de notificação e de registro, e os requisitos [...]
On March 1, 2023 in China, the Rules established by the National Medical Products Administration (NMPA) and the Center for Medical [...]
On 20 March 2023, Regulation 2023/607 was finally published in the Official Journal of the European Union EUR- Lex, which formalises [...]
The Department of Health, Health Canada published the Fees in Respect of Drugs and Medical Devices Order, the annual adjustment of [...]
According to Circular No. MDS-CIR-001-V1/220324 published by SFDA (Saudi Food and Drug Authority, the Saudi Arabian Regulatory Authority for Medical Devices [...]
The topic of cybersecurity is increasingly important nowadays, especially in critical areas such as public health and the medical sector: for [...]
As previously announced, technical safety tests are a key component of the registration process for Medical Devices in China. In this [...]
During the consultation that ended on 23rd November, MHRA submitted proposals to change the mandatory registration fees for Medical Devices that [...]
On 6th January, the European Commission issued a proposal to extend the transitional period under Art. 120 for MDR until [...]
Health Canada, the department of the Government of Canada responsible for national health policy, last 21st November issued a reminder for [...]